Skip to main content
Livermore
Livermore
ZHEN

Two Sigma Advisers, LP

SEC CIK
0001478735
Latest filing
Aug 14, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of CYTK by Two Sigma Advisers, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−174,700−100.0%Sold outHolders
Q4 2025174,700$11.1M<0.1%+174,700NewHolders
Q2 20250$00.0%−80,400−100.0%Sold outHolders
Q1 202580,400$3.23M<0.1%−146,000−64.5%ReducedHolders
Q4 2024226,400$10.6M<0.1%+11,700+5.4%AddedHolders
Q3 2024214,700$11.3M<0.1%+214,700NewHolders
Q2 20240$00.0%−7,000−100.0%Sold outHolders
Q1 20247,000$490.8K<0.1%−76,800−91.6%ReducedHolders
Q4 202383,800$7.00M<0.1%−93,100−52.6%ReducedHolders
Q3 2023176,900$5.21M<0.1%−101,500−36.5%ReducedHolders
Q2 2023278,400$9.08M<0.1%−178,600−39.1%ReducedHolders
Q1 2023457,000$16.1M<0.1%+2,000+0.4%AddedHolders
Q4 2022455,000$20.8M0.1%+53,100+13.2%AddedHolders
Q3 2022401,900$19.5M0.1%−62,500−13.5%ReducedHolders
Q2 2022464,400$18.2M0.1%−114,900−19.8%ReducedHolders
Q1 2022579,300$21.3M0.1%−199,800−25.6%ReducedHolders
Q4 2021779,100$35.5M0.1%−40,800−5.0%ReducedHolders
Q3 2021819,900$29.3M0.1%−57,100−6.5%ReducedHolders
Q2 2021877,000$17.4M<0.1%−98,300−10.1%ReducedHolders
Q1 2021975,300$22.7M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.